Skip to main content
TipRanks
Go Ultimate75% OFF

OncoArendi Therapeutics SA (1B1) Q2 2023 Earnings Report

0 Followers

DE:1B1 Q2 2023 EPS Results

Actual EPS
-EUR 0.07
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.06

DE:1B1 Q2 2023 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
EUR 22.61K
Beat/Miss
Missed by -EUR 22.61K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
09/29/2023
Time
Before Open
Conference Call
Friday, September 29, 2023
DE:1B1 Upcoming Earnings

OncoArendi Therapeutics SA's next earnings date is estimated for April 6, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:1B1 Earnings History

DE:1B1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 06, 20272026 (Q4)―--0.02――
Oct 30, 20262026 (Q3)―--0.06―
Sep 30, 20262026 (Q2)―-0.02-0.0443.53% (+0.02)
Apr 30, 20262026 (Q1)―--0.06―
Mar 31, 20262025 (Q4)―-0.02-0.1283.78% (+0.10)
Oct 31, 20252025 (Q3)―--0.08―
Sep 30, 20252025 (Q2)―-0.04-0.162.96% (+0.07)
Apr 30, 20252025 (Q1)―--0.09―
Mar 31, 20252024 (Q4)―-0.12-0.2348.30% (+0.11)
Oct 15, 20242024 (Q3)―-0.08-0.06-48.80% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed